Nav: Home

New research about new treatments/methods

October 24, 2007



(Monday, October 22, 11:30 AM EST)

Video-assisted thoracic surgery (VATS) often results in thoracotomy due to visual limitations, but a new 'tattooing' procedure may help slow this trend, according to a new study. Researchers from Saint Vincent's Catholic Medical Center, NY, and Franklin Square Hospital Center, MD, stained the pulmonary nodules of four patients preparing for VATS with dye, prior to surgery. They reported that the 'tattooing' of the nodules enabled for precise locatablilty and aided in directing the depth of the resection. Researchers suggest that this procedure is feasible and safe, and minimizes the conversions from VATS to thoracotomies.



(Monday, October 22, 3:30 PM EST)

A new study suggests that pneumonia patients are treated more quickly and accurately when hospitals implement a collaborative process. During a 2-year period, researchers from Cedars Sinai Medical Center applied a 'collaborative review' process and a 'shared accountability' process, when treating patients with community acquired pneumonia (CAP), who were admitted through the emergency department. After implementation, researchers found that over 90% of antibiotic timing rates complied with performance measures.



(Tuesday, October 23, 11:30 AM EST)

Patients who suffer from inoperable, stage I non-small cell lung cancer (NSCLC) may have a non-surgical alternative, reports new research. A study from Georgetown University studied the outcomes of radiosurgery in 20 patients with NSCLC, using an instrument called CyberKnife, with real-time tumor motion tracking. After the treatment, patients received CT imaging and lung function testing at 6 and 12 months. Researchers report the treatment as well tolerated, with a crude survival rate of 95% at 12 months.



(Tuesday, October 23, 3:30 PM EST)

Patients with congestive heart failure (CHF) may benefit from an outpatient, comprehensive disease management and rehabilitation program (CDMR), says a new study. Researchers from Loma Linda Medical Center studied two groups of CHF patients. Both received education and training in CHF management, but only one group participated in a 12-week CDMR program. Results showed that patients in the CDMR program had improved survival rates at 48 months, as well as long-term improvement in medication adherence and smoking cessation, and fewer hospital visits.



(Wednesday, October 24, 1:30 PM EST)

New research from Thailand suggests modified Tai Chi exercises may be helpful for COPD rehabilitation. The combination of graceful body movements and pursed-lip breathing was found to improve maximum and functional exercise capacities, and overall quality of life in patients with COPD. Researchers suggest Tai Chi training could provide an effective, inexpensive, and non-traumatic training program for patients.



(Wednesday, October 24, 1:30 PM EST)

The use of human fibrin sealant, special glue used to seal air leaks during lung resection surgery, is yielding positive results, according to new research. The study, from George Washington University and the Washington Institute of Thoracic and Cardiovascular Surgery, gathered and reviewed the success rates of the sealant in 74 patients who underwent lung resection. Researchers report superior results in those patients who received the sealant, and suggest that this product may provide greater patient comfort, lower complications, shorter hospitalization, and reduced cost.



(Wednesday, October 24, 1:30 PM EST)

Body mass index (BMI) and apnea hypopnea index (AHI) show no relation to premature ventricular arrhythmias (PVC) in patients with obstructive sleep apnea (OSA), according to a new study. However the researchers, from Lutheran Medical Center and SUNY-Downstate Medical Center in New York, say that treatment with continuous positive airway pressure (CPAP) decreases the incidence of both AHI and PVC. The significant decrease in PVC may be the result of decreased transmural pressure, say researchers.



(Wednesday, October 24, 1:30 PM EST)

New research from St. Joseph's Regional Medical Center in New Jersey assessed the frequency of drug resistance between tuberculosis (TB) patients with and without HIV. Researchers reviewed the medical records of more than 200 patients with pulmonary TB from 1999-2007, and compared the data with previously complied results from 1995-1998. They found that while the overall frequency of multi-drug resistant TB declined in HIV patients, it still remained more frequent in the HIV patients, when compared to those TB patients without HIV.



(Wednesday, October 24, 3:00 PM EST)

Sildenafil may be the best treatment for pulmonary arterial hypertension (PAH), according to new research. The study, from the Medical University of South Carolina, found that when compared to six other treatments, Sildenafil was the most inexpensive and resulted in a greater gain in quality-adjusted life years. Researchers suggest physicians take the life-styles of their patients into account when prescribing PAH medications.

American College of Chest Physicians

Related Hiv Patients Articles:

Tobacco the 'silent killer' of HIV patients, say researchers
Researchers at the University of York have shown that tobacco use is more common among HIV positive individuals than HIV negative individuals.
Highlighting the clinical complications associated with ART in HIV/TB coinfected patients
Today Future Science Group announces the publication of an article in Future Virology highlighting the clinical complications associated with antiretroviral therapy in Chinese HIV/ Tuberculosis (TB) coinfected patients.
HIV patients have nearly twice the heart attack risk
Current methods to predict the risk of heart attack and stroke vastly underestimate the risk in individuals with HIV, which is nearly double that of the general population, reports a new study.
HIV patients showing signs of multidrug resistance in Africa
Significant numbers of patients whose HIV strains developed resistance to older generation drugs are also resistant to modern drugs, finds a new study led by UCL (University College London) and funded by Wellcome.
Patients diagnosed late with HIV infection are more likely to transmit HIV to others
An estimated 1.2 million people live with HIV in the United States, with nearly 13 percent being unaware of their infection.
HIV: Identification of receptors in patients spontaneously controlling infection
A small number of patients infected by HIV spontaneously control viral replication without antiretroviral therapy, and do not develop the disease.
HIV-infected patients more likely to lack cancer treatment
A new study finds HIV-infected patients with cancer in the United States appear to be less likely to receive cancer treatment, regardless of insurance and other existing health conditions.
New drug combination treats hepatitis C patients also infected with HIV
Researchers at the University of California, School of Medicine found a new combination that effectively treats hepatitis C patients co-infected with human immunodeficiency virus type 1 (HIV).
Microclinics help keep Kenyan HIV patients in care
The results showed that microclinics cut in half the normal rate of disengagement from care, which was defined as missing a clinic appointment by 90 days or more, when compared to the control group, and reduced the perceived stigma of HIV by 25 percent within the larger community.
Microclinics help keep Kenyan HIV patients in care
A team led by researchers from UC San Francisco, Organic Health Response, and Microclinic International is reporting results of a study that showed significant benefits of microclinics -- an innovative intervention that mobilized rural Kenyan HIV patients' informal social networks to support their staying in care.

Related Hiv Patients Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...